Literature DB >> 36147388

An unusual case of eosinophilia, myalgia and skin contractures: Shulman's disease revisited.

R K Anadure1, S Shankar2, Aneesh Mohimen3, Arpitha Pemmaraju4, Jitumani Kalita5.   

Abstract

Shulman's disease (eosinophilic fasciitis) is a very rare autoimmune disorder with an unknown etiopathogenesis. During the initial period of disease, it usually causes limb and trunk edema followed by collagenous thickening of the subcutaneous fascia. Eosinophilia is a predominant laboratory finding during the initial phase of the disease and less prominent in the later phases. Patients may also present with arthritis, myositis, peripheral neuropathy, and rarely pleuropericarditis. Here, we are reporting a case of eosinophilic fasciitis presenting with vague constitutional symptoms, fever, and peripheral blood eosinophilia followed by rapidly evolving skin tightening with joint contractures and muscle stiffness, which misled the treating team toward Scleroderma and its overlap syndromes. The diagnosis was finally clinched by a full-thickness skin biopsy along with underlying fascia and muscle tissue from an effected area, with a gratifying treatment response to standard immune suppression.
© 2020 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.

Entities:  

Keywords:  Eosinophilia; Eosinophilic fasciitis; Groove sign; Shulman's disease

Year:  2020        PMID: 36147388      PMCID: PMC9485746          DOI: 10.1016/j.mjafi.2019.12.006

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  10 in total

1.  Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis.

Authors:  M Jinnin; H Ihn; K Yamane; Y Asano; N Yazawa; K Tamaki
Journal:  Br J Dermatol       Date:  2004-08       Impact factor: 9.302

Review 2.  Eosinophilic Skin Diseases: A Comprehensive Review.

Authors:  Hai Long; Guiying Zhang; Ling Wang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

3.  Diffuse fasciitis with eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  Trans Assoc Am Physicians       Date:  1975

4.  Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.

Authors:  David Lebeaux; Camille Francès; Stéphane Barete; Bertrand Wechsler; Odile Dubourg; Jérôme Renoux; Thierry Maisonobe; Olivier Benveniste; Marc Gatfossé; Pierre Bourgeois; Zahir Amoura; Patrice Cacoub; Jean-Charles Piette; Damien Sène
Journal:  Rheumatology (Oxford)       Date:  2011-11-25       Impact factor: 7.580

Review 5.  Eosinophilic fasciitis (Shulman disease).

Authors:  David Lebeaux; Damien Sène
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-08       Impact factor: 4.098

Review 6.  Diagnosis and classification of eosinophilic fasciitis.

Authors:  I Pinal-Fernandez; A Selva-O' Callaghan; J M Grau
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

Review 7.  Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.

Authors:  Lindsay Bischoff; Chris T Derk
Journal:  Int J Dermatol       Date:  2008-01       Impact factor: 2.736

8.  Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.

Authors:  V Falanga; T A Medsger
Journal:  J Am Acad Dermatol       Date:  1987-10       Impact factor: 11.527

9.  Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases.

Authors:  S Lakhanpal; W W Ginsburg; C J Michet; J A Doyle; S B Moore
Journal:  Semin Arthritis Rheum       Date:  1988-05       Impact factor: 5.532

Review 10.  Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.

Authors:  Yukie Endo; Atsushi Tamura; Youichiro Matsushima; Tomoko Iwasaki; Michiko Hasegawa; Yayoi Nagai; Osamu Ishikawa
Journal:  Clin Rheumatol       Date:  2007-03-08       Impact factor: 3.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.